Event-Driven Stocks

Guardian Pharmacy Services, Inc.

GRDNNYSE

Consumer Discretionary · Retail-Drug Stores and Proprietary Stores · GA · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 7 gooddetails ↓

Financials

SEC XBRL · annual
 FY25FY24
Revenue$1.45B$1.23B
Operating income$72.7M−$62.9M
Net income$49.2M−$110.0M
Total assets$412.7M$320.8M
Total liabilities$194.7M$170.8M
Equity$217.9M$150.0M
EPS (diluted)——
Shares out.——

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
5.0%
Net margin
3.4%
Return on equity
22.6%
Return on assets
11.9%
Return on capital (ROCE)
28.9%
Liabilities / assets
47.2%
Debt / equity
0.89×
Book value / share
—
Revenue growth (YoY)
17.9%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
3.85safe
Accruals / assets
−12.4%clean
Beneish M-Score
-2.95normal
Piotroski F-Score
7/8strong

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
93
/ 100
Profitability 100Growth 100Catalyst 67Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 7 good
  • Operating margin is positive
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20262.8M6.3+2.6%
Apr 30, 20262.7M8.2+7.0%
Apr 15, 20262.5M4.7-13.5%
Mar 31, 20262.9M3.7+48.8%
Mar 13, 20262.0M5.5+9.2%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗
  • 8-KMay 28, 2026
  • 4May 7, 2026
  • 4May 7, 2026
  • 4May 7, 2026
  • 8-KMay 7, 2026
  • S-8May 6, 2026
  • S-3ASRMay 6, 2026
  • 10-QMay 6, 2026
  • 8-KMay 6, 2026
  • SCHEDULE 13GMay 6, 2026
  • 3Apr 13, 2026
  • 3Apr 13, 2026
  • 3Apr 13, 2026
  • 3Apr 13, 2026
  • 3Apr 13, 2026

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.